Plasma ofCS-modified CD44 predicts the survival of patients with lung cancer. Wu ZY, Yang DW, He YQ, Wang TM, et al. Cancer Sci 2024 Aug 27. doi: 10.1111/cas.16319.

Read + Share

Amedeo Smart

Independent Medical Education

Wu ZY, Yang DW, He YQ, Wang TM, et al. Plasma ofCS-modified CD44 predicts the survival of patients with lung cancer. Cancer Sci 2024 Aug 27. doi: 10.1111/cas.16319.
PMID: 39192543